Anthropometry in 5- to 9-year-old greenlandic and ukrainian children in relation to prenatal exposure to perfluorinated alkyl substances

Environmental Health Perspectives

Volumn 123, Issue 8, 2015, Pages 841-846

  Høyer, Birgit Bjerre ^a   Ramlau Hansen, Cecilia Høst ^b   Vrijheid, Martine ^c,d,e   Valvi, Damaskini ^c,d,e   Pedersen, Henning Sloth ^f   Zviezdai, Valentyna ^g   Jönsson, Bo A G ^h   Lindh, Christian H ^h   Bonde, Jens Peter ⁱ   Toft, Gunnar ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f Primary Health Care Clinic Godthaab   (Greenland)

^g KHARKIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^h LUND UNIVERSITY   (Sweden)

ⁱ BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; POLLUTANT;

ANTHROPOMETRY; ARTICLE; BODY MASS; DENMARK; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; HUMAN; INFANT; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; OBESITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; UKRAINIAN (PEOPLE); WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO; CHEMICALLY INDUCED; CHILD; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; GREENLAND; POLLUTANT; PREGNANCY; PRESCHOOL CHILD; TOXICITY; UKRAINE;

ANIMALIA;

ALKANESULFONIC ACIDS; ANTHROPOMETRY; CAPRYLATES; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; GREENLAND; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; UKRAINE;

EID: 84938351421     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408881     Document Type: Article

References (36)

1. Andersen CS, Fei C, Gamborg M, Nohr EA, Sørensen TI, Olsen J. 2010. Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy. Am J Epidemiol 172(11): 1230-1237; doi: 10. 1093/aje/kwq289.
2. Andersen CS, Fei C, Gamborg M, Nohr EA, Sørensen TI, Olsen J. 2013. Prenatal exposures to perfluorinated chemicals and anthropometry at 7 years of age. Am J Epidemiol 178(6): 921-927; doi: 10. 1093/aje/kwt057.
3. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. 2007. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115: 1670-1676; doi: 10. 1289/ehp. 10334.
4. Blüher S, Molz E, Wiegand S, Otto KP, Sergeyev E, Tuschy S, et al. 2013. Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab 98(8): 3384-3393; doi: 10. 1210/jc. 2013-1389.
5. Chen MH, Ha EH, Wen TW, Su YN, Lien GW, Chen CY, et al. 2012. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS One 7(8): e42474; doi: 10. 1371/journal. pone. 0042474.
6. de Koning L, Merchant AT, Pogue J, Anand SS. 2007. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 28(7): 850-856; doi: 10. 1093/eurheartj/ehm026.
7. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. 2007. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85(9): 660-667.
8. D'eon JC, Simpson AJ, Kumar R, Baer AJ, Mabury SA. 2010. Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy. Environ Toxicol Chem 29(8): 1678-1688; doi: 10. 1002/etc. 204.
9. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. 2006. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 59(10): 1087-1091; doi: 10. 1016/j. jclinepi. 2006. 01. 014.
10. Du G, Hu J, Huang H, Qin Y, Han X, Wu D, et al. 2013a. Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo. Environ Toxicol Chem 32(2): 353-360; doi: 10. 1002/etc. 2034.
11. Du G, Huang H, Hu J, Qin Y, Wu D, Song L, et al. 2013b. Endocrine-related effects of perfluoro-octanoic acid (PFOA) in zebrafish, H295R steroido-genesis and receptor reporter gene assays. Chemosphere 91(8): 1099-1106; doi: 10. 1016/j. chemosphere. 2013. 01. 012.
12. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115: 1677-1682; doi: 10. 1289/ehp. 10506.
13. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2008. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol 168(1): 66-72; doi: 10. 1093/aje/kwn095.
14. Fromme H, Tittlemier SA, Völkel W, Wilhelm M, Twardella D. 2009. Perfluorinated compounds-exposure assessment for the general population in western countries. Int J Hyg Environ Health 212(3): 239-270; doi: 10. 1016/j. ijheh. 2008. 04. 007.
15. Goulding A, Taylor RW, Grant AM, Parnell WR, Wilson NC, Williams SM. 2010. Waist-to-height ratios in relation to BMI z-scores in three ethnic groups from a representative sample of New Zealand children aged 5-14 years. Int J Obes (Lond) 34(7): 1188-1190; doi: 10. 1038/ijo. 2009. 278.
16. Halldorsson TI, Rytter D, Haug LS, Bech BH, Danielsen I, Becher G, et al. 2012. Prenatal exposure to perfluoro octanoate and risk of over-weight at 20 years of age: a prospective cohort study. Environ Health Perspect 120: 668-673; doi: 10. 1289/ehp. 1104034.
17. Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE. 2009. Phenotypic dichotomy following developmental exposure to perfluoro-octanoic acid (PFOA) in female CD-1 mice: low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol 304(1-2): 97-105; doi: 10. 1016/j. mce. 2009. 02. 021.
18. Høyer BB, Ramlau-Hansen CH, Henriksen TB, Pedersen HS, Góralczyk K, Zviezdai V, et al. 2014. Body mass index in young school-age children in relation to organochlorine compounds in early life: a prospective study. Int J Obes (Lond) 38(7): 919-925; doi: 10. 1038/ijo. 2014. 58.
19. Lindh CH, Rylander L, Toft G, Axmon A, Rignell-Hydbom A, Giwercman A, et al. 2012. Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European popula-tions. Chemosphere 88(11): 1269-1275; doi: 10. 1016/j. chemosphere. 2012. 03. 049.
20. Maffeis C, Banzato C, Talamini G, Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. 2008. Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr 152(2): 207-213; doi: 10. 1016/j. jpeds. 2007. 09. 021.
21. Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J. 2007. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 80(7): 643-648; doi: 10. 1007/s00420-006-0165-9.
22. Mokha JS, Srinivasan SR, Dasmahapatra P, Fernandez C, Chen W, Xu J, et al. 2010. Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study. BMC Pediatr 10: 73; doi: 10. 1186/1471-2431-10-73.
23. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. 2008. Effects of endocrine disrup-tors on obesity. Int J Androl 31(2): 201-208; doi: 10. 1111/j. 1365-2605. 2007. 00858. x.
24. Ngo HT, Hetland RB, Sabaredzovic A, Haug LS, Steffensen IL. 2014. In utero exposure to perfluorooctanoate (PFOA) or prefluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice. Environ Res 132: 251-263; doi: 10. 1016/j. envres. 2014. 03. 033.
25. Ohmori K, Kudo N, Katayama K, Kawashima Y. 2003. Comparison of the toxicokinetics between perfluo-rocarboxylic acids with different carbon chain length. Toxicology 184(2-3): 135-140.
26. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluoro-octanoate in retired fluorochemical production workers. Environ Health Perspect 115: 1298-1305; doi: 10. 1289/ehp. 10009.
27. Rosen MB, Lee JS, Ren H, Vallanat B, Liu J, Waalkes MP, et al. 2008. Toxicogenomic dissec-tion of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPARα and CAR. Toxicol Sci 103(1): 46-56; doi: 10. 1093/toxsci/kfn025.
28. Schellong K, Schulz S, Harder T, Plagemann A. 2012. Birth weight and long-term overweight risk: systematic review and a meta-analysis including 643, 902 persons from 66 studies and 26 countries globally. PLoS One 7(10): e47776; doi: 10. 1371/journal. pone. 0047776.
29. Shi Z, Zhang H, Ding L, Feng Y, Xu M, Dai J. 2009. The effect of perfluorododecanonic acid on endocrine status, sex hormones and expression of steroidogenic genes in pubertal female rats. Reprod Toxicol 27(3-4): 352-359; doi: 10. 1016/j. reprotox. 2009. 02. 008.
30. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. 2009. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338: b2393; doi: 10. 1136/bmj. b2393.
31. Textor J, Hardt J, Knüppel S. 2011. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 22(5): 745; doi: 10. 1097/EDE. 0b013e318225c2be.
32. Toft G, Axmon A, Giwercman A, Thulstrup AM, Rignell-Hydbom A, Pedersen HS, et al. 2005. Fertility in four regions spanning large contrasts in serum levels of widespread persistent organochlorines: a cross-sectional study. Environ Health 4: 26; doi: 10. 1186/1476-069X-4-26.
33. U. S. Environmental Protection Agency. 2010. 2010/2015 PFOA Stewardship Program. Available: http://www. epa. gov/opptintr/pfoa/pubs/stewardship/[accessed 1 April 2014].
34. Vanden Heuvel JP, Kuslikis BI, Van Ragelghem ML, Peterson RE. 1991. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J Biochem Toxicol 6: 83-92.
35. Wolf DC, Moore T, Abbott BD, Rosen MB, Das KP, Zehr RD, et al. 2008. Comparative hepatic effects of perfluorooctanoic acid and WY 14, 643 in PPAR-α knockout and wild-type mice. Toxicol Pathol 36(4): 632-639; doi: 10. 1177/0192623308318216.
36. Zou G. 2004. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7): 702-706.